Table 2:

Difference in times between Notice of Compliance and pan-Canadian Pharmaceutical Alliance decision

Time intervalYearNo. of drugsMedian time, d
Marketing date and decision by pan-Canadian Pharmaceutical Alliance2011–2020156354–650
Marketing date and decision by pan-Canadian Pharmaceutical Alliance by therapeutic value2011–2020155Major: 333
Moderate: 482
Little to no additional therapeutic value: 459
Notice of Compliance date and decision by pan-Canadian Pharmaceutical Alliance2011–2020156438–704
Notice of Compliance date and date CADTH submission filed2011, 2012–2018, 2018–20201522011: 66
2012–2018: 4
2018–2020: −13